New MD Anderson-Developed Breast Cancer Staging System Emphasizes Importance of Tumor Biology as Prognostic Indicator (The University of Texas MD Anderson Cancer Center)

A new breast cancer staging system developed by researchers at The University of Texas MD Anderson Cancer Center finds that incorporating tumor biology is a critical prognostic indicator for women who undergo neoadjuvant, or pre-surgical, therapy for breast cancer. The University of Texas MD Anderson Cancer Center is one of the 26 NCCN Member Institutions. ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news